Overview Fundamentals API Earnings EOD API Sample Code Pricing

Erasca Inc (ERAS NASDAQ) stock market data APIs

$2.62 -0.1(-3.7%) as of November 1, 2024
Price chart is built with Anychart

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Erasca Inc Financial Data Overview

2.72
2.62
-
2.72
2.615
1.51-3.45
768 M
283 M
0
-0.29
1.161
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ERAS',
Type: 'Common Stock',
Name: 'Erasca Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00MTSR883',
ISIN: NULL,
CUSIP: NULL,
CIK: '1761918',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-07-16',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Erasca Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -143 948 992
  • Earnings Per Share -0.93
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Erasca Inc Earnings via APIs

  • Latest Release 2024-08-13
  • EPS/Forecast -0.18

Get Erasca Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com